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ABSTRACT: Caloric restriction (CR) is an intervention that
can increase maximal lifespan in organisms, but its application
to humans remains challenging. A more feasible approach to
achieve lifespan extension is to develop CR mimetics that
target biochemical pathways affected by CR. Recent studies in
the engineering and structural characterization of polyketide
synthases (PKSs) have facilitated their use as biocatalysts to
produce novel polyketides. Here, we show that by establishing
a combinatorial biosynthetic route in Escherichia coli and
exploring the substrate promiscuity of a mutant PKS from
alfalfa, 413 potential anti-ageing polyketides were biosynthe-
sized. In this approach, novel acyl-coenzyme A (CoA)
precursors generated by promiscuous acid-CoA ligases were
utilized by PKS to generate polyketides which were then fed to
Caenorhabditis elegans to study their potential efficacy in lifespan extension. It was found that CR mimetics like resveratrol can
counter the age-associated decline in mitochondrial function and increase the lifespan of C. elegans. Using the mitochondrial
respiration profile of C. elegans supplemented for 8 days with 50 μM resveratrol as a blueprint, we can screen our novel
polyketides for potential CR mimetics with improved potency. This study highlights the utility of synthetic enzymology in the
development of novel anti-ageing therapeutics.
1. INTRODUCTION
Caloric restriction (CR) is defined as a reduction of caloric
intake by 30−40% of ad libitum consumption, without causing
malnutrition.1 CR can cause lifespan extension by triggering a
shift from a physiological state of proliferation and growth, to
repair and maintenance. Studies have shown that CR reduces
oxidative damage, retards age-related functional decline such as
deteriorations in DNA repair capacity, and causes a 30%
increase in maximal lifespan of mammals.2−4 Nevertheless, the
amount and duration of CR necessary to extend lifespan is not
practical in humans.5 A feasible solution lies in developing a
CR mimetic that can directly target biochemical pathways
affected by CR and similarly achieve lifespan extension.
Natural products represent a good starting point for drug
discovery, and there is great interest in synthesizing analogs of
these compounds in order to explore the mechanism of action,
and enhance bioactivity and bioavailability. Polyketides are
functionally and structurally diverse secondary metabolites
produced in bacteria, fungi, and plants. Many of these bioactive
natural products have significant medical applications,6
including their use as immunosuppressants,7 antibiotics,8 and
potential anti-ageing therapeutics.9 Resveratrol is hypothesized
to be a CR mimetic10,11 as it increases mitochondrial resistance
to oxidative stress and extends the lifespan of Caenorhabditis
elegans.12 Although resveratrol confers some anti-ageing
benefits, its application in humans is fraught with challenges.
One problem of administering resveratrol in humans is its low
solubility and high metabolism, resulting in low bioavail-
ability.13 Moreover, some research has suggested that
resveratrol may have potential adverse effects like nephrotox-
icity.14,15 The corollary to these challenges requires a need to
discover new CR mimetics that are more potent (increased
bioavailability and efficacy) in bringing about lifespan
extension in humans.
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Polyketides are typically biosynthesized through successive
decarboxylative condensations of coenzyme A (CoA)-derived
precursors, into a complex polycyclic multi-carbon compound
containing keto or hydroxyl groups.16 Because of the chemical
and structural complexity of polyketides and their derivatives,
chemical synthesis is difficult. Current research in the
engineering and structural characterization of polyketide
synthases (PKSs) has facilitated their use as biocatalysts to
generate novel polyketides, which can serve as potential drug
leads.17
Type III PKSs are homodimeric and acyl-carrier protein-
independent enzymes which can accomplish a series of
decarboxylative condensations and cyclization reactions within
a single active site. The relative simplicity, flexibility, and
unusually broad substrate specificity of type III PKSs make
them ideal candidates for engineering, facilitating the
accessibility of bioactive polyketide libraries which are
otherwise not easily available.18,19 One of the most well-
understood type III PKS is chalcone synthase (CHS), which is
ubiquitous in higher plants and crucial for plant metabolism
and defense.18,20 Chalcone synthesis by CHS is initiated by the
loading of p-coumaroyl-CoA onto the active site cysteine
residue; CHS then catalyzes three iterative decarboxylative
condensations of the extender substrate, malonyl-CoA, with
the cysteine-bound starter substrate, to form a linear
tetraketide intermediate. Subsequently, the intermediate
undergoes an intramolecular C6 to C1 Claisen condensation
and cyclizes into chalcone, which undergoes a further Michael-
type ring closure to form naringenin.20
Unlike CHSs which are ubiquitous, stilbene synthases
(STSs) are found in only a small subset of unrelated plants.
Structure-based mutagenic transformation of alfalfa CHS into
STS established that modulations in active-site residues
enabled STSs to catalyze an intramolecular C2 to C7 aldol
condensation, followed by decarboxylation and dehydration to
produce a stilbene scaffold.21 Eighteen distal amino acid
residues in alfalfa CHS spanning from residue 98 to 268 were
mutated, resulting in a mutant CHS with STS activity
(18xCHS). The 18xCHS was able to produce resveratrol as
the major product, instead of naringenin, when incubated with
p-coumaroyl-CoA and malonyl-CoA.
An exploration of substrate and product profiles of 18xCHS
across various acyl-CoA classes has not been systematically
reported. Previous substrate specificity studies have demon-
strated the production of unnatural polyketides by the
promiscuous alfalfa CHS.22 However, because of a lack of
means to deliver novel acyl-CoA precursors, these studies were
limited to structural derivatives of cognate substrates from the
cinnamyl-CoA and malonyl-CoA families. Originating from the
promiscuous alfalfa CHS scaffold and with the ability to
produce the CR mimetic resveratrol, 18xCHS provided an
excellent platform for the engineered biosynthesis of novel
stilbenes and other polyketides with potential anti-ageing
activities. Using precursor-directed combinatorial biosynthesis,
unnatural acyl-CoA production by promiscuous CoA-ligases
was coupled to polyketide biosynthesis by 18xCHS. By
establishing the substrate specificities of 18xCHS, polyketide
libraries can be synthesized and screened for anti-ageing
properties.
The conventional way of anti-ageing drug screening is via
lifespan assays. However, lifespan assays are time-consuming
and impractical for screening a large library of bioactive
compounds. This study aims to develop a medium throughput
screening methodology by conducting mitochondrial function
assays on C. elegans exposed to various compounds using an
Extracellular Flux Analyzer. By periodically introducing
pharmacological agents such as electron transport chain
inhibitors to manipulate mitochondrial activity and respiratory
function, the mitochondrial biology of C. elegans can be
examined to establish a correlation between oxygen con-
sumption rates (OCRs), CR mimetics, and lifespan extension.
2. RESULTS AND DISCUSSION
2.1. Establishing a Combinatorial Biosynthetic Route
in Escherichia coli. Precursor-directed combinatorial biosyn-
thesis is a useful means to generate polyketide analogs. As
Figure 1. E. coli constructs generated for in vivo precursor-directed combinatorial biosynthesis of polyketides. Constructs containing the CoA
ligases with an empty Tom-15b vector served as controls during the subsequent high-performance liquid chromatography (HPLC) analyses. When
a starter acid such as p-coumaric acid and an extender acid such as malonic acid are introduced to the E. coli constructs, the respective CoA
thioesters are formed, which are utilized by 18xCHS to form polyketides like resveratrol.
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starter and extender CoA thioesters were either commercially
unavailable or cost prohibitive, and the biosynthesis of CoA
thioesters had to be coupled to PKS, 18xCHS, in order to
generate polyketides (Figure 1). By supplying p-coumaric acid
and malonic acid to the E. coli constructs, p-coumaroyl-CoA
and malonyl-CoA were synthesized by 4-coumarate-CoA ligase
(4CL) and malonyl-CoA synthetase (MCS), respectively.
18xCHS was validated to have resveratrol synthase activity
when incubated with the biosynthesized p-coumaroyl-CoA and
malonyl-CoA (Figure S1 in the Supporting Information). The
resveratrol generated by 18xCHS was verified to have an
experimental mass of 227.0712 in the negative MS mode
(theoretical mass of 227.0714) (Figure S2 in the Supporting
Information), and NMR analysis further established the
identity of the compound (Figure S3 in the Supporting
Information). Several minor peaks were also observed at
retention times of 24.4, 35.0, and 40.4 min, indicating the
potential biosynthesis of bisnoryangonin, p-coumaroyl triacetic
acid lactone, naringenin, as well as other polyketides resulting
from a different number of extension step or minor products
derived from alternate intramolecular cyclization. This allowed
us to set up the platform for precursor-directed combinatorial
biosynthesis, which requires the utilization of different
combinations of acyl-CoA derivatives for the generation of
novel polyketides.
Through precursor-directed biosynthesis using different
combinations of 69 starter CoA thioesters and 12 extender
malonyl-CoA derivatives (Table S1 in the Supporting
Information), the substrate profile of 18xCHS was established
(Figure 2), and a catalog of polyketides was obtained based on
HPLC analyses. 18xCHS was found to be promiscuous in
substrate utilization, consistent with previously characterized
alfalfa CHS.22 18xCHS was able to utilize unnatural starter and
extender CoA thioesters as substrates for polyketide synthesis
(Figure 3), thus highlighting the feasibility of precursor-
directed combinatorial biosynthesis of polyketides. From the
matrix of substrates used, at least 413 novel polyketides were
generated.
2.2. Starter Acyl-CoA Substrate Preference. 18xCHS
was able to use cinnamyl-CoA (Table S2 in the Supporting
Information), phenylpropanoyl-CoA (Table S2 in the
Supporting Information), benzoyl-CoA (Table S3 in the
Supporting Information), phenylacetyl-CoA (Table S4 in the
Supporting Information), bicyclic aromatic CoA (Table S4 in
the Supporting Information), and saturated and unsaturated
aliphatic CoA thioester derivatives (Table S5 in the Supporting
Information) as starter substrates, in combination with various
malonyl-CoA derivatives as the extender substrate (Figure 4).
Interestingly, benzoyl-CoA derivatives were the most preferred
starters (65.8% of the combinations led to new products
formed), followed by unsaturated aliphatic CoA derivatives
(61.7% of the combinations), phenylacetyl-CoA derivatives
(51.4% of the combinations), cinnamyl-CoA derivatives (50%
of the combinations), saturated aliphatic CoA derivatives
(36.5% of the combinations), phenylpropanoyl-CoA deriva-
tives (22.6% of the combinations), and bicyclic aromatic CoA
derivatives (12.5% of the combinations).
Among the cinnamyl-CoA derivatives, meta-substituted and
para-substituted derivatives were most preferred (62.5 and
60.7% of the combinations, respectively, led to new products
formed), compared to ortho-substituted (25% of the
combinations) and aliphatic chain-substituted (45.8% of the
combinations) derivatives. This suggests that the presence of
substituents at the ortho position may affect the interaction of
the starter unit with the active-site residues of 18xCHS, causing
ortho-substituted cinnamyl-CoA derivatives to be utilized less
efficiently. This is consistent with previous work on alfalfa
CHS by Jez and co-workers, which reported that the catalytic
efficiency of alfalfa CHS is lower when 2-hydroxycinnamyl-
CoA is used, compared to 3-hydroxycinnamyl-CoA and 4-
hydroxycinnamyl-CoA.22 Interestingly, 2-hydroxyphenylacetyl-
CoA (reacted with 4 out of 12 extenders) was also less readily
utilized by 18xCHS compared to 4-hydroxyphenylacetyl-CoA
(reacted with 8 out of 12 extenders), which is structurally
similar to, but shorter than p-coumaroyl-CoA by a carbon unit.
When substituent groups are present on the extender acyl-
CoA substrate, cinnamyl-CoA derivatives are no longer
strongly preferred. Instead, smaller and more flexible starters
Figure 2. Substrate profile of 18xCHS using 69 starter CoA thioesters
and 12 extender CoA thioesters; 413 out of 828 possible
combinations (49.9%) gave rise to new polyketides. Extender acyl-
CoAs are abbreviated as follows: malonyl-CoA (Mal), methylmalonyl-
CoA (MeMal), ethylmalonyl-CoA (EtMal), isopropylmalonyl-CoA
(IsoMal), butylmalonyl-CoA (ButMal), allylmalonyl-CoA (AlMal),
hydroxymalonyl-CoA (OHMal), fluoromalonyl-CoA (FMal), chlor-
omalonyl-CoA (ClMal) and bromomalonyl-CoA (BrMal), phenyl-
malonyl-CoA (PhMal), and 3-thiophenemalonyl-CoA (3ThMal).
Figure 3. HPLC profile of organic extracts from E. coli constructs
grown in M9 supplemented with 2-flurocinnamate and butylmalonate.
Biosynthesized products in spent minimal medium containing either
E. coli with CoA ligases + 18xCHS or E. coli with CoA ligases only
(control construct) were extracted and subjected to HPLC analysis.
An additional peak at retention time 38.7 min was observed in the
extract containing the 18xCHS construct, but was not present in the
extract containing the control construct, indicating that a new
polyketide was biosynthesized when 2-fluorocinnamyl-CoA and
butylmalonyl-CoA were supplemented to 18xCHS.
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like benzoyl-CoA derivatives and unsaturated aliphatic CoA
derivatives are more easily accepted by 18xCHS, together with
unnatural malonyl-CoA derivatives to form unique polyketides.
Most benzoyl-CoA derivatives were utilized as starters,
regardless of the position of the substituent groups (ortho
position: 63.9% of the combinations led to new products
formed, meta position: 62.5% of the combinations, para
position: 58.3% of the combinations), suggesting that the
benzoyl-CoA backbone is small enough to participate in
reactions with bulky extenders. For unsaturated aliphatic CoA
derivatives, smaller starters with a butenoyl-CoA backbone
were most preferred (70.8% of the combinations led to new
products formed), followed by those with a pentenoyl-CoA
backbone (62.5% of the combinations), and those with a
hexenoyl-CoA backbone (41.7% of the combinations). This is
consistent with previous studies on Scutellaria baicalensis CHS,
which proposed that bulkier starter substrates contributed to
unfavorable steric effects when additional substituent groups
were present in the extender acyl-CoA used.23
Surprisingly, other than derivatives of the cognate substrates,
18xCHS could also utilize chemically distinct starter acyl-CoAs
beyond its canonical substrate pool. In particular, we have
shown for the first time that 18xCHS could accept bicyclic
aromatic CoA thioesters together with malonyl-CoA deriva-
tives to form novel polyketides (6 out of 48 combinations led
to new products formed). This substrate promiscuity can be
attributed to substrate mimicry, illustrating how slight
substrate resemblance to the cognate substrates can play a
role in starter unit recognition in 18xCHS and subsequently,
the biosynthesis of novel polyketides (Figure 5).
2.3. Extender Acyl-CoA Substrate Preference. The
repertoire of novel polyketides biosynthesized from the 69 ×
12 assays also provided insights into the extender substrate
preference of 18xCHS. By collating the number of starter acyl-
CoAs that reacted with each extender substrate (Figure 2), the
order of preference for extender acyl-CoA substrates for
18xCHS was established: 3-thiophenemalonyl-CoA > phenyl-
malonyl-CoA = fluoromalonyl-CoA > chloromalonyl-CoA >
ethylmalonyl-CoA > malonyl-CoA > methylmalonyl-CoA >
hydroxymalonyl-CoA > butylmalonyl-CoA = bromomalonyl-
CoA > allylmalonyl-CoA > isopropylmalonyl-CoA. It was likely
that the extender substrate preference of 18xCHS was
dependent on the stability of the carbanion intermediate
generated during catalysis.
When the extender acyl-CoA enters the active site of
18xCHS, it is decarboxylated to form a carbanion intermediate
which can attack the starter unit or elongate polyketide bound
to the catalytic cysteine residue in the active site. This
carbanion intermediate is stabilized by a resonance effect in all
the malonyl-CoA derivatives, aided by the nearby His303 and
Asn336 residues (numbering in alfalfa CHS). Certain
substituent groups in the malonyl-CoA derivatives can affect
the degree of stabilization of the carbanion intermediate. For
instance, 3-thiophenemalonyl-CoA and phenylmalonyl-CoA
were strongly preferred compared to the other extenders
(Figure 2), perhaps because of the presence of the aromatic
ring which can confer additional stability via resonance effects
(Figure 6).
Among the halogen-substituted malonyl-CoA derivatives,
the fluoro-substituted malonyl-CoA derivative has the greatest
inductive effect because of the high electronegativity of the
fluorine atom. Thus, the carbanion intermediate is greatly
stabilized and fluoromalonyl-CoA is the preferred extender,
compared to chloromalonyl-CoA and bromomalonyl-CoA.
This is a finding similar to the extender acyl-CoA substrate
preference of a type III PKS from Oryza sativa, where
fluoromalonyl-CoA is one of the most preferred extender
compared to the other 11 that were tested.24
Figure 4. Substrate profile of 18xCHS based on the seven starter substrate families. Benzoyl-CoA derivatives were the most preferred starters while
bicyclic aromatic CoA derivatives were least preferred by 18xCHS. A total of at least 413 novel polyketides were biosynthesized.
Figure 5. Structural mimicry of bicyclic aromatic CoA thioesters. The
mimicry to phenylacetyl-CoA (for 1-naphthalenecarboxyl-CoA) and
cinnamyl-CoA (for 2-naphthalenecarboxyl-CoA and 2-quinolinecar-
boxyl-CoA) is highlighted in blue.
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Compared to the aromatic malonyl-CoA derivatives, the
aliphatic derivatives such as malonyl-CoA, methylmalonyl-
CoA, ethylmalonyl-CoA, isopropylmalonyl-CoA, butylmalonyl-
CoA, and allylmalonyl-CoA generated a range of novel
polyketides with 21−39 starters out of the 69 starter substrates
tested. However, the order of preference was not manifested as
a significant trend. Taken together, by determining the
substrate preference of 18xCHS, a library of novel polyketides
with potential anti-ageing utility can be biosynthesized.
2.4. Mass Spectrometry Profiling of Novel Polyke-
tides. The substrate profile of 18xCHS was confirmed by
determining the mass of the polyketide products using mass
spectrometry (MS). Selected combinations of starters and
extenders were used to generate polyketides, which were then
purified by HPLC and analyzed by MS. Most of the masses of
the selected polyketides identified in this study matched their
corresponding expected masses, and some of the potential
chemical structures of the compounds were proposed (Table
S6 in the Supporting Information). The exact identities of
these products, however, require further validation by NMR
analyses. In some instances, cyclization of the polyketide
intermediate may not have occurred and the active-site
cysteine-bound intermediate is hydrolyzed to form the
corresponding acid, which may undergo decarboxylation to
form a novel polyketide (Figure 7). In other cases, some of
these polyketides could be truncated side products generated
from the 18xCHS reaction, which include polyketides with
fewer polyketide extension steps, or those that were
biosynthesized through a lactonization, aldol or Claisen
condensation of the linear polyketide intermediate (Figure
S4 in the Supporting Information).
Many of the starter and extender substrates used in this
research study have not been explored in previous studies, and
the product library biosynthesized is expected to comprise
novel polyketides with chalcone, stilbene, and lactone scaffolds.
It has been shown that MS analysis provides an idea of the
identity of the new products from precursor-directed
combinatorial biosynthesis. These polyketides can then be
further characterized by NMR to determine their chemical
structure and properties. By obtaining a profile of novel
polyketides, the compound library can subsequently be applied
to drug screening efforts, such as the development of anti-
ageing therapeutics.
2.5. Lifespan Assays Using Resveratrol or Novel
Polyketides. Studies on resveratrol have revealed the
compound to be a potential CR mimetic.10 When 50 μM
resveratrol was introduced to C. elegans, a significant lifespan
extension was observed when compared to controls fed with
dimethyl sulfoxide (DMSO) (Figure 8A). C. elegans eat-2
mutants have a pharyngeal pumping defect, which results in
compromised food intake25 and consequently chronic CR.
Similar to resveratrol-treated C. elegans, eat-2 mutants have a
longer lifespan compared to their wild-type counterparts
(Figure 8B), suggesting an association between resveratrol
and CR. Nevertheless, studies have shown that resveratrol is
rapidly metabolized when ingested, and it has a broad
spectrum of activity in various cellular components.10,15
Hence, issues of bioavailability and adverse effects warrant
the search for other CR mimetics that are more potent than
resveratrol.
Of the 413 novel polyketides, 24 were tested for anti-ageing
properties in a C. elegans lifespan assay (Table S7 in the
Supporting Information). Most of the tested combinations had
no significant effects on the lifespan of wild-type N2 C. elegans
except for the products derived from 3-chlorocinnamyl-CoA +
malonyl-CoA and 3-(3′-chloro-4′-methoxy)phenylpropanoyl-
CoA + methylmalonyl-CoA which had toxic effects and led to
a shorter lifespan compared to the control (Figure 9).
Interestingly, worms treated with 3-(3′-chloro-4′-methoxy)-
phenylpropanoic acid, methylmalonic acid, and the control E.
coli construct had a mean lifespan of 26.5 days. This suggests
that the acids used or the CoA esters produced could have
some effects on the lifespan of wild-type C. elegans. More
studies are needed to verify the biological effects of these
compounds.
Although the 18xCHS strain can produce resveratrol when
supplemented with p-coumaric acid and malonic acid, a
significant lifespan extension effect was not observed. This is
due to the low concentration of resveratrol biosynthesized by
the E. coli constructs growing on the nematode growth media
(NGM) agar plates (approximately 1 μM from HPLC
analysis). Even though the concentration of novel polyketides
being biosynthesized is low, we hope to identify anti-ageing
compounds that can work well even at low doses. This may
Figure 6. Resonance structures depicting the stabilization of the
carbanion of 3-thiophenemalonyl-CoA after decarboxylation.
Figure 7. Potential polyketide formed from one unit of p-coumaroyl-CoA and butylmalonyl-CoA without cyclization.
ACS Omega Article
DOI: 10.1021/acsomega.8b01620
ACS Omega 2018, 3, 11050−11061
11054
lead to the development of an anti-ageing drug lead that has
minimal adverse effects common with resveratrol treatment.
2.6. C. elegans Respiration Assays Using Resveratrol
or Novel Polyketides. Despite the utility of lifespan assays,
they are rather time-consuming as the average lifespan of C.
elegans is 3 weeks. Hence, there is a need to develop a higher
throughput method to screen our library of compounds for
anti-ageing properties. Since CR is known to promote
longevity by modulating oxidative metabolism,26 it would be
logical to look at the mitochondrial activity of C. elegans when
they were exposed to potential CR mimetics. Mitochondrial
function assays were developed and optimized in order to
establish a correlation between OCRs, mitochondrial activity,
and longevity.
It was observed that C. elegans exposed to 8 days of 50 μM
resveratrol have a higher average basal OCR, higher average
maximal OCR, and higher spare respiratory capacity (Figure
10) when compared to their controls. This suggested that
exposure to a potential CR mimetic for at least 8 days can
counteract the age-related decline in the mitochondrial
function in C. elegans by increasing the average basal
respiration, average maximal respiration, and spare respiratory
capacity. The increase in spare respiratory capacity was
Figure 8. (A) Survival plots of C. elegans fed with 50 μM commercially available resveratrol (green) or 0.1% DMSO (blue). Worms exposed to 50
μM resveratrol had a significantly longer mean lifespan (27.4 days) compared to the DMSO control (17.1 days). (B) Survival plots of wild-type N2
(blue) and eat-2 (green) C. elegans. eat-2 mutants had a significantly longer mean lifespan (17.6 days) compared to the wild-type worms (14.3
days). The p-values were calculated using log rank test, and a p-value ≤ 0.05 is considered to be statistically significant.
Figure 9. Survival plots of N2 C. elegans fed with either 18xCHS E. coli strain (green) or control E. coli strain (blue) supplemented with 3-
chlorocinnamic acid + malonic acid (left) or 3-(3′-chloro-4′-methoxy)phenylpropanoic acid + methylmalonic acid (right). Worms exposed to the
novel polyketides produced from these two combinations of starter and extender acids had a significantly shorter mean lifespan compared to the
control which is exposed to the respective carboxylic acids and CoA esters only.
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indicative of improvements in the ability of the mitochondria
to cope with changes in ATP demand.
Our findings supported a recent study which also observed
an increase in the C. elegans basal mitochondrial respiration
rate when the worms were exposed to resveratrol.9 A likely
hypothesis for this intriguing observation is that resveratrol can
mimic a CR state, which causes metabolism to shift away from
glycolysis toward respiration in order to maintain body
Figure 10. Wild-type N2 worms exposed to 8 days of 50 μM resveratrol had a significantly higher basal OCR, maximal OCR, and spare respiratory
capacity compared to N2 worms exposed to 5-fluoro-2′-deoxyuridine (FUdR) or FUdR + 0.1% DMSO. Consistent with results using the CR
mimetic resveratrol, eat-2 mutants undergo chronic CR and have a higher basal respiration, maximal respiration, and spare respiratory capacity
compared to wild-type C. elegans. Introducing 50 μM resveratrol to eat-2 mutants does not improve their mitochondrial function further. FUdR:
worms exposed to FUdR treatment only; DMSO: worms exposed to FUdR + 0.1% DMSO; Resv: worms exposed to FUdR + 50 μM resveratrol.
*p-value ≤ 0.05; **p-value ≤ 0.01; ***p-value ≤ 0.001; ****p-value ≤ 0.0001.
Figure 11. Butylmalonic acid and p-coumaric acid were incorporated into NGM agar together with either the control (Ctrl) or 18xCHS E. coli
construct. C. elegans exposed to novel polyketides and CoA esters produced by the 18xCHS E. coli construct (contains CoA ligases + 18xCHS) do
not have a higher basal respiration, maximal respiration, and spare respiratory capacity compared to C. elegans exposed to CoA esters only (control
construct contains CoA ligases only).
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function.27,28 This eventually results in elevated electron
transport, respiration, and ROS production. Low exposure to
a greater oxidative stress triggers a secondary adaptive response
called mitohormesis in the host’s defence system, leading to
better stress resistance and lifespan extension.26,29
In addition, C. elegans eat-2 mutants exhibited a higher basal
OCR, maximal OCR, and spare respiratory capacity compared
to wild-type worms (Figure 10). This is consistent with the
effects of the CR mimetic resveratrol on mitochondrial
function, highlighting the potential of mitochondrial function
assays in screening for CR mimetics. Nevertheless, subjecting
eat-2 mutants to resveratrol treatment did not result in further
increases in basal OCR, maximal OCR, and spare respiratory
capacity. This suggested a strain on the mitochondrial function
of the eat-2 mutants which were already experiencing chronic
CR; subjecting the mutants to further CR mimetic exposures
could have detrimental effects on mitochondrial function.
Indeed, eat-2 mutants exposed to 50 μM resveratrol treatment
exhibited a shorter mean lifespan (15.9 days) as compared to
eat-2 mutants which were exposed to 0.1% DMSO (20.0 days)
(p-value = 0.006).
CR in C. elegans has been demonstrated to induce catalase
enzyme activity and improve oxidative stress resistance,
resulting in a longer lifespan.26 Sufficient evidence has pointed
to the fact that resveratrol can mimic some aspects of CR, and
can extend the lifespan of model organisms like C. elegans,
although the detailed mechanism of action is still unknown.
This study, along with research by other researchers,28,30,31
suggests that lifespan, mitochondrial function, CR, and CR
mimetics are intricately linked.
As a proof of concept, a few novel polyketides from our
compound library were tested in mitochondrial function
assays, but so far, none of them significantly improved the
mitochondrial function of wild-type C. elegans. For instance,
when butylmalonic acid and p-coumaric acid were incorpo-
rated into the NGM agar together with either the control or
the 18xCHS E. coli construct, N2 worms exposed to the novel
polyketides, butylmalonyl-CoA, and p-coumaroyl-CoA did not
have a significantly higher basal respiration, maximal
respiration, and spare respiratory capacity compared to
worms exposed to the CoA esters only (Figure 11).
Interestingly, the toxic polyketides derived from 3-chlorocin-
namyl-CoA + malonyl-CoA and 3-(3′-chloro-4′-methoxy)-
phenylpropanoyl-CoA + methylmalonyl-CoA did not have any
effect on the mitochondrial respiration of C. elegans, suggesting
that other pathways are affected by the toxicity instead.
Taken together, the development of mitochondrial function
assays allows us to screen our libraries for anti-ageing
compounds more efficiently without having to conduct lengthy
lifespan assays. The anti-ageing properties of selected drug hits
can subsequently be validated by conventional lifespan assays
and other functional assays.
2.7. Synthetic Enzymology in a Probiotic System.
Once a promising anti-ageing drug with minimal adverse
effects is developed, we can either deploy the drug directly in
humans or incorporate the combinatorial biosynthetic pathway
(of the drug) into a probiotic strain such as E. coli Nissle 1917.
Thus, other than preventing diseases of the gastrointestinal
tract, the probiotic Nissle strain can lead to a sustainable
biosynthesis of anti-ageing drugs within the human host.
Although more research and development is required, we have
taken the first steps toward using probiotics in anti-ageing drug
delivery: we have constructed a combinatorial biosynthetic
pathway involving phenylalanine ammonia lyase (PAL) as an
enzyme upstream of the acid-CoA ligases and 18xCHS. PAL is
able to deaminate endogenous phenylalanine and tyrosine to
cinnamic acid and p-coumaric acid, respectively, while 4CL can
make use of these carboxylic acids to generate starter acyl-
CoAs for 18xCHS for the biosynthesis of potential anti-ageing
compounds (Figure 12). As a proof of concept, our engineered
E. coli Nissle strain is capable of producing resveratrol at 4.1
mg/L (Figure 13), a concentration comparable to that found
in red wine (average 1.9 ± 1.7 mg/L).32 Nutraceuticals are
food or formulations of food that provide health or medical
benefits such as the prevention or treatment of diseases.33 This
engineered strain of probiotic E. coli Nissle presents a potential
vehicle for delivery of anti-ageing compounds to the human
body without the need to take drugs orally or intravenously.
3. CONCLUSIONS
In summary, a major limitation in anti-ageing therapeutic
development lies in the production of novel and bioactive lead
compounds for screening. By establishing a combinatorial
biosynthetic route in E. coli and exploring the substrate
promiscuity of 18xCHS, 413 potential anti-ageing compounds
were biosynthesized. Resveratrol is postulated to be a CR
mimetic and has been shown to extend the lifespan of several
model organisms. Using the OCR profile of worms exposed to
8 days of 50 μM resveratrol as a blueprint, libraries of novel
polyketides can be screened to identify potential CR mimetics.
A molecular screening platform where compound libraries are
screened in C. elegans-based mitochondrial function assays can
Figure 12. Combinatorial biosynthesis of resveratrol or other anti-ageing polyketides in E. coli Nissle.
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thus be developed. We believe that these studies will augment
current understanding toward polyketide compound library
biosynthesis and provide an additional tool for anti-ageing
therapeutic development.
4. MATERIALS AND METHODS
4.1. Reagents. The carboxylic acid substrates for acid-CoA
ligases were obtained from Sigma-Aldrich Co. (St. Louis, MO,
USA), Tokyo Chemical Industry Co. (Tokyo, Japan),
Extrasynthese Co. (Genay Cedex, France), and Lier Chemical
Co. (Sichuan, People’s Republic of China). A total of 81
carboxylic acids were utilized as precursors for acyl-CoA
thioester biosynthesis catalyzed by four acyl-CoA ligases.34 The
acids were from the malonate, cinnamate, phenylpropanoate,
benzoate, phenylacetate, naphthalene, quinoline, saturated
aliphatic, and unsaturated aliphatic families.
A total of 12 malonate-type acids were used as extender
substrates for the precursor-directed combinatorial biosyn-
thesismalonic acid, methylmalonic acid, ethylmalonic acid,
isopropylmalonic acid, butylmalonic acid, allylmalonic acid,
hydroxymalonic acid, fluoromalonic acid, chloromalonic acid,
bromomalonic acid, phenylmalonic acid, and 3-thiophenema-
lonic acid. Starter substrates were composed of 69 carboxylic
acids(cinnamate type) cinnamic acid, 2-fluorocinnamic acid,
3-fluorocinnamic acid, 4-fluorocinnamic acid, α-fluorocinnamic
acid, 3-chlorocinnamic acid, 3-chloro-4-methoxycinnamic acid,
4-chlorocinnamic acid, 2-hydroxycinnamic acid, 4-hydroxycin-
namic acid (also known as p-coumaric acid), 3-methoxy-4-
hydroxycinnamic acid, 4-methoxycinnamic acid, 4-methylcin-
namic acid, α-methylcinnamic acid; (phenylpropanoate type)
3-phenylpropanoic acid, 3-(3′-chloro)phenylpropanoic acid, 3-
(3′-chloro-4′-methoxy)phenylpropanoic acid, 3-(3′,4′-
dihydroxy)phenylpropanoic acid, 3-(3′-methoxy)-
phenylpropanoic acid, 3-(4′-methoxy)phenylpropanoic acid,
3-(4′-fluoro)phenylpropanoic acid; (benzoate type) benzoic
acid, 2-fluorobenzoic acid, 3-fluorobenzoic acid, 4-fluoroben-
zoic acid, 2,6-difluorobenzoic acid, 2-chlorobenzoic acid, 3-
chlorobenzoic acid, 4-chlorobenzoic acid, 2-bromobenzoic
acid, 3-bromobenzoic acid, 4-bromobenzoic acid, 2-iodoben-
zoic acid, 2-hydroxybenzoic acid, 2,3-dihydroxybenzoic acid,
2,4-dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid, 2-
methoxybenzoic acid, 2-methylbenzoic acid, 3-aminobenzoic
acid, 4-aminobenzoic acid; (phenylacetate type) phenylacetic
acid, 2-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid,
4-methoxyphenylacetic acid, phenoxyacetic acid, phenylpyruvic
acid; (naphthalene and quinoline type) 1-naphthalenecarbox-
ylic acid, 2-naphthalenecarboxylic acid, 2-quinolinecarboxylic
acid, 3-quinolinecarboxylic acid; (saturated aliphatic type)
propanoic acid, butanoic acid, pentanoic acid, hexanoic acid,
heptanoic acid, octanoic acid, nonanoic acid, decanoic acid;
and (unsaturated aliphatic type) 2-butenoic acid, 2-methyl-2-
butenoic acid, 3-methyl-2-butenoic acid, 3-butenoic acid, 2-
pentenoic acid, 3-pentenoic acid, 4-pentenoic acid, 3-methyl-4-
pentenoic acid, 3-hexenoic acid, and 5-hexenoic acid. The
chemical structures of all substrates tested are depicted in
Table S1 in the Supporting Information.
4.2. Establishing a Combinatorial Biosynthetic Route
in E. coli. The type III PKS used in this research study is a
mutant CHS with STS activity from Medicago sativa that was
previously created by Austin et al. in 2004. Alfalfa CHS (GI:
166363) was cloned from M. sativa cDNA library into a
modified pET-15b vector (Tom-15b vector) containing ten
histidine tags at the N-terminus of the protein. PCR-mediated
mutagenesis was conducted with reference to the paper
published by Austin et al. (2004) in order to replicate the
same mutations in alfalfa CHS, resulting in 18xCHS which has
STS activity. In particular, the following sites were mutated
D98A, V100L, V101A, V102M, T131S, S133T, G134T,
V135P, M137L, Y158V, M159G, M160V, Y161F, Q163H,
L268K, K269G, D270A, and G273D.21
The cloning of the four acyl-CoA ligases were previously
reported.34 They are MCS (GI: 3982573) from Rhizobium
trifolii, phenylacetate-CoA ligase (PCL) (GI: 1102907) from
Streptomyces coelicolor A3(2), benzoate-CoA ligase (BZL) (GI:
1040685) from Rhodopseudomonas palustri, and 4-coumarate-
CoA ligase (4CL) (GI: 12229632) from Nicotiana tabacum. In
order to establish a combinatorial biosynthetic route in E. coli,
three CoA ligases (4CL, PCL, and BZL) involved in the
generation of starter CoA thioesters were subcloned into the
multiple cloning site 1 of a pRSFDuet-1 vector (Novagen)
separately. To produce the extender CoA thioesters, MCS and
PCL were each subcloned into the MCS2 region of the same
vector. Thereafter, the constructed plasmid was co-transformed
with the Tom-15b vector containing 18xCHS into E. coli
Rosetta II (DE3) strain (Novagen). Depending on the identity
of the starter and extender acids, E. coli harboring the
appropriate combination of CoA ligases was used for the in
vivo precursor-directed combinatorial biosynthesis of poly-
ketides (see Table S1 in the Supporting Information). An E.
coli construct without the 18xCHS gene was also prepared to
serve as a control for the subsequent detection of novel
polyketides. A matrix of 69 starter acids and 12 extender acids
were separately introduced to the engineered E. coli host cells,
giving a possible combination of 828 substrate profiles in total.
An E. coli Nissle 1917 Δalr ΔdadX strain which requires 50
μg/mL D-alanine for growth and an alr+ plasmid (pEaaK) for
complementation was previously described.35 PAL (GenBank:
X51513.1) from Rhodosporidium toruloides, 4CL, and 18xCHS
were cloned into the pEaaK vector under a constitutive J23119
promoter, TTGACAGCTAGCTCAGTCCTAGGTA-
TAATGCTAGC. E. coli Nissle 1917 Δalr ΔdadX strain
complemented with the pEaaK vector construct was grown in
LB or M9 minimal medium in the absence of exogenous D-
alanine.
Figure 13. HPLC profile of organic extracts from E. coli Nissle
constructs grown in M9 supplemented with 0.25 mM tyrosine. A peak
corresponding to p-coumarate is present in extracts from Nissle
constructs containing PAL and absent in the extract from the Nissle
construct with an empty vector, indicating that PAL is active. In
addition, resveratrol is produced by the Nissle construct containing
PAL, 4CL, and 18xCHS.
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4.3. In Vivo Precursor-Directed Combinatorial Bio-
synthesis of Polyketides and HPLC Analysis. The E. coli
host cells harboring the biosynthetic genes were first grown in
LB containing 30 μg/mL kanamycin, 34 μg/mL chloramphe-
nicol, and 100 μg/mL ampicillin at 25 °C. When OD600nm
reached 0.6, protein expression was induced by 0.1 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) for 16 h. The
cells were subsequently pelleted and resuspended in M9
minimal medium containing antibiotics, 0.1 mM IPTG, 1 mM
starter acid, and 1 mM extender acid, and incubated at 25 °C
for a further 72 h. The supernatant was acidified to pH 3.0 with
6 M HCl and extracted with ethyl acetate thrice. The organic
solvent was subsequently removed by a vacuum concentrator,
and the residue was dissolved in 100 μL DMSO for HPLC
analysis.
The Atlantis analytical C18 reverse-phase column (Waters)
was first equilibrated with 10% acetonitrile, 0.1% trifluoroacetic
acid (TFA) in water at a flow rate of 1 mL/min for 15 min.
The sample (10 μL) was then loaded onto the column, and the
mobile phase was changed to 50% acetonitrile, 0.1% TFA in
water under a linear gradient over a period of 40 min at a flow
rate of 1 mL/min. For the next 5 min, a linear gradient to
100% acetonitrile containing 0.1% TFA was conducted. The
eluted compounds were detected by measuring the absorbance
at 230, 280, and 320 nm. Chromatogram peaks that were
present (minimum absorbance of 20 mAU) in the extracts of
constructs containing 18xCHS but absent in the extracts of
control constructs indicate the occurrence of polyketide
biosynthesis.
4.4. MS Profiling of Novel Polyketides. HPLC−MS/MS
analysis of the purified polyketides was carried out on QTOF
6550 with iFunnel and turbo ion spray, connected to UHPLC
1290 (Agilent, Singapore). The Phenomenex Synergy-Polar
C18, with a 2.1 mm × 50 mm column and a 3 μm particle size
(Phenomenex, US), was first equilibrated with 5% acetonitrile,
0.2% formic acid in water for 1 min at a flow rate of 600 μL/
min. The samples were dissolved in 100 μL acetonitrile, and 2
μL was loaded for the analysis. Separation of the polyketides
was performed with a gradient from 5% acetonitrile, 0.2%
formic acid in water to 90% acetonitrile, 0.2% formic acid in
water over 5 min; 90% acetonitrile, 0.2% formic acid in water
was then maintained for another 1 min, with the column
temperature set at 40 °C throughout the run. The mass
spectrometer was set to an MS scan range of 100−1400 m/z at
1 scan/s, and the three most intense precursor ions were
selected for fragmentation at a fixed collision energy of 35.
Data were recorded with MassHunter acquisition B6.0
(Agilent) and analyzed with MassHunter Qualitative Analysis
software version 6 (Agilent). After MS detection, NMR
analyses of selected compounds were carried out by the
Nuclear Magnetic Resonance Laboratory (Department of
Chemistry, National University of Singapore).
4.5. Lifespan Assays Using Resveratrol or Novel
Polyketides. Wild-type C. elegans N2 strain and eat-2 mutant
strain were used in lifespan assays. C. elegans were maintained
according to Stiernagle (2006) with minimal changes.36
Resveratrol (50 μM, TCI Co.) or DMSO (as a control) was
incorporated into 5 cm NGM agar plates by another lab
member to ensure blinding of the assays. NGM plates used for
lifespan assays also contained 90 μM FUdR (Sigma-Aldrich
Co.) to ensure batch synchrony by preventing cell division and
growth in newly hatched C. elegans.37 Cultures of E. coli OP50
strain were grown in LB overnight at 25 °C and concentrated
10-fold by centrifugation and resuspension in a smaller volume
of LB. OP50 was then spotted onto NGM agar plates as a food
source for C. elegans and allowed to dry overnight at room
temperature. C. elegans were cultured at 20 °C on the various
NGM agar plates containing a lawn of E. coli OP50. The
worms were examined daily and scored as dead if no response
was observed when they were gently prodded with a platinum
wire. C. elegans that were lost because of crawling on the walls
of the agar plates were omitted from analysis. Survival analysis
was conducted using the log rank test in the IBM SPSS
Statistics 22 program.
For lifespan assays using novel polyketides, selected
combinations of 0.5 mM starter acids and 1 mM extender
acids together with 90 μM FUdR, 30 μg/mL kanamycin, 34
μg/mL chloramphenicol, 100 μg/mL ampicillin, and 0.1 mM
IPTG were incorporated into NGM agar plates. The
corresponding CoA ligases + 18xCHS E. coli constructs and
constructs without 18xCHS were grown in LB with antibiotics
overnight at 25 °C by another lab member to ensure blinding
of the lifespan studies. Protein expression was induced by 0.1
mM IPTG for 3 h at 25 °C, and 0.5 mM starter acids and 1
mM extender acids were subsequently introduced to the
culture. After incubation at 25 °C for another 3 h, the E. coli
culture was concentrated 20-fold, seeded onto the respective
NGM plates, and allowed to dry overnight at room
temperature as the food source which can expose C. elegans
to the biosynthesized polyketides concurrently. The lifespans
of wild-type N2 C. elegans exposed to the CoA thioesters and
novel polyketides were compared to the lifespans of N2 worms
exposed to CoA thioesters only, using the log rank test.
4.6. C. elegans Respiration Assays Using Resveratrol
or Novel Polyketides. Oxygen consumption was measured
using the Seahorse XFe24 Extracellular Flux Analyzer (Sea-
horse Bioscience). C. elegans were recovered from NGM plates
using M9 minimal medium and washed four times to eliminate
eggs and residual bacteria.38 The worms were transferred to
24-well seahorse islet plates (10−25 worms in 675 μL M9
minimal medium per well) and covered with an islet capture
screen. Basal oxygen consumption was measured for six cycles
before performing carbonylcyanide p-trifluoromethoxy-phenyl-
hydrazone (FCCP) treatment at a final concentration of 20
μM. Maximal oxygen consumption was subsequently measured
for eight cycles. The Kruskal−Wallis test in the GraphPad
Prism 6 program was used to determine the significance of
differences in medians. Subsequently, Dunn’s multiple
comparisons test was used to determine if the medians varied
significantly between any two selected groups.
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